We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

100 hedge funds and large institutions have $284M invested in Provention Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $5.1M | Put options by funds: $1.99M

68% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 28

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $294M → $284M (-$10.5M)

6% less funds holding

Funds holding: 106 → 100 (-6)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
47
Reduced
28
Closed
16
Calls
$5.1M
Puts
$1.99M
Net Calls
+$3.11M
Net Calls Change
-$3.66M

Top Buyers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
+$11.4M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$6.03M
3
BlackRock
BlackRock
New York
+$5.41M
4
Northern Trust
Northern Trust
Illinois
+$4.8M
5
Two Sigma Investments
Two Sigma Investments
New York
+$4.8M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$7.22M
2
JJIJ
Johnson & Johnson Innovation - JJDC
New Jersey
-$6.95M
3
Millennium Management
Millennium Management
New York
-$5.87M
4
MIM
Monashee Investment Management
Massachusetts
-$3.53M
5
PA
Perceptive Advisors
New York
-$3.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
51
American International Group
New York
$365K +$32.1K +2,545 +10%
UBS AM
52
UBS AM
Illinois
$350K – – –
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$350K +$22.1K +1,749 +7%
RJFSA
54
Raymond James Financial Services Advisors
Florida
$348K -$21.4K -1,692 -6%
CAM
55
ClariVest Asset Management
California
$336K -$20.2K -1,600 -6%
Ameriprise
56
Ameriprise
Minnesota
$335K +$16.8K +1,330 +5%
B
57
Bailard
California
$313K – – –
CS
58
Credit Suisse
Switzerland
$311K +$6.23K +493 +2%
Jane Street
59
Jane Street
New York
$309K -$189K -14,982 -38%
AQR Capital Management
60
AQR Capital Management
Connecticut
$300K +$295K +23,372 New
Barclays
61
Barclays
United Kingdom
$292K +$287K +22,744 New
VEA
62
Virtus ETF Advisers
New York
$276K -$36.8K -2,916 -12%
IA
63
IndexIQ Advisors
New York
$262K +$14K +1,106 +6%
CSS
64
Cubist Systematic Strategies
Connecticut
$253K -$429K -33,990 -63%
Lido Advisors
65
Lido Advisors
California
$252K – – –
MIM
66
MetLife Investment Management
New Jersey
$252K – – –
JP Morgan Chase
67
JP Morgan Chase
New York
$226K +$44K +3,486 +24%
CHAM
68
Clear Harbor Asset Management
Connecticut
$205K – – –
Simplex Trading
69
Simplex Trading
Illinois
$203K +$53.3K +4,223 +36%
VOYA Investment Management
70
VOYA Investment Management
Georgia
$198K +$10.3K +819 +6%
RJA
71
Raymond James & Associates
Florida
$197K +$67.2K +5,320 +53%
TI
72
Trexquant Investment
Connecticut
$194K +$191K +15,104 New
Cambridge Investment Research Advisors
73
Cambridge Investment Research Advisors
Iowa
$187K -$6.32K -500 -3%
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
$177K +$2.4K +190 +1%
MLICM
75
Metropolitan Life Insurance Company (MetLife)
New York
$174K – – –
1 2
3
4 5

PRVB Hedge Fund Activity: Q3 2020 in Review

100 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q3 2020, worth a combined $284M — down 3.6% from $294M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of PRVB and 10 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 47 added.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $11.4M. The largest seller was Citigroup, cutting an estimated $7.22M.

  • 100 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q3 2020, down from 106 in Q2 2020.
  • Funds reported $284M of Provention Bio, Inc. Common Stock stock for Q3 2020, down 3.6% quarter-over-quarter.
  • 10 funds opened new Provention Bio, Inc. Common Stock positions in Q3 2020 and 16 closed out, a net change of -6 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q3 2020 was Gilder Gagnon Howe & Co, an estimated $11.4M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q3 2020 was Citigroup, an estimated $7.22M sold.

Based on aggregated 13F filings for Q3 2020.